HT
BLUE

Headlands Technologies’s bluebird bio BLUE Stock Holding History

Headlands Technologies’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$6 – 1212
2024
Q2 		– Sell
-251
Closed -$5.03K – 1098
2024
Q1 		$6.43K Buy
+251
New +$6.43K ﹤0.01% 1076
2023
Q4 		– Sell
-7
Closed -$441 – 964
2023
Q3 		$441 Sell
7
-306
-98% -$21.5K ﹤0.01% 872
2023
Q2 		$20.6K Buy
+313
New +$22.9K 0.01% 563

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Headlands Technologies's BLUE Position: Q3 2024 in Review

Headlands Technologies held its bluebird bio (BLUE) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1212.

Headlands Technologies first reported a position in BLUE in Q2 2023 and has held it in 3 quarters since. The position peaked at $20.6K in Q2 2023. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.

  • Headlands Technologies held 0 shares of bluebird bio worth $0 as of Q3 2024.
  • Headlands Technologies left its bluebird bio share count unchanged in Q3 2024.
  • bluebird bio made up ﹤0.01% of Headlands Technologies's portfolio in Q3 2024, its #1212 holding.
  • Headlands Technologies first reported a position in bluebird bio in Q2 2023 and has held it in 3 quarters since.
  • Headlands Technologies's bluebird bio position peaked at $20.6K in Q2 2023.
  • 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.

Based on Headlands Technologies's 13F filing for Q3 2024, filed 12 Nov 2024.